Sublingual Microcirculation Data of Patients With Systemic Diseases

NCT ID: NCT02516215

Last Updated: 2016-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

360 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-30

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observational clinical study, patients with systemic diseases will be enrolled according to the inclusion and exclusion criteria. 360 patients will received the examination of sublingual microcirculation by using sidestream dark filed video microscope. The microcirculation data includes total small vessel density, perfused small vessel density, microvascular flow index, and heterogeneity index. The patients will be divided into right groups according to their systemic diseases as follows: group 1 hypertension (60 patients), group 2 diabetes mellitus (60), group 3 hypertension and diabetes mellitus (60), group 4 end stage renal disease with hemodialysis (60), group 5 peripheral arterial occlusive disease (30), group 6 coronary artery disease (30), group 7 liver cirrhosis (30), and group 8 anemia (30).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sublingual Microcirculation Status

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1_Hypertension

Patients with diagnosed hypertension, without other systemic diseases

No intervention

Intervention Type OTHER

2_Diabetes mellitus

Patients with diagnosed diabetes mellitus, without other systemic diseases

No intervention

Intervention Type OTHER

3_Hypertension and diabetes mellitus

Patients with both diagnosed hypertension and diabetes mellitus

No intervention

Intervention Type OTHER

4_end stage renal disease with hemodialysis

Patients with end stage renal disease with hemodialysis

No intervention

Intervention Type OTHER

5_Peripheral arterial occlusive disease

Patients with disgnosed peripheral arterial occlusive disease

No intervention

Intervention Type OTHER

6_Coronary artery disease

Patients with diagnosed coronary artery disease

No intervention

Intervention Type OTHER

7_liver cirrhosis

Patients with diagnosed liver cirrhosis

No intervention

Intervention Type OTHER

8_Anemia

Patients with diagnosed anemia

No intervention

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged from 20 to 79 years old
* BMI ranged from 18.5 to 27 kg/m2
* Presence of one of the condition

1. Diagnosed hypertenison \> 6 months, without other systemic diseases
2. Diagnosed diabetes mellitus \> 6 monthes, without other systemic diseases
3. Diagnosed with both hypertension and diabetes mellitus \> 6 months, without other systemic diseases
4. Diagnosed with end stage renal disease and recevied renal replacement therapy \> 6 months
5. Diagnosed with peripheral arterial occlusive diseases \> 6 months
6. Diagnosed with coronary artery disease \> 6 months
7. Diagnosed with liver cirrhosis \> 6 months
8. Diagnosed with anemia \> 6 months, hemoglobin level \< 10 g/dL

Exclusion Criteria

* Diagnosed with sepsis, major tauma, or admission to ICU within one month
* Body temperature higher than 37.5 ℃ or lower than 35.5 ℃
* Any on of the following condition

1. Asthma
2. Chronic obstructive pulmonary disease
3. Endocrine diseases
4. Hematological disorders
5. Uncured cancer
6. Chronic uncured infection
7. Other major disease with limited daily activity
* Non-native speakers
Minimum Eligible Age

20 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu-Chang Yeh, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University Hospital, Department of Anesthesiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital, anesthesiology department

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yu-Chang Yeh, M.D., Ph.D

Role: CONTACT

886-2-23123456 ext. 62158

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yu-Chang Yeh, M.D, Ph.D.

Role: primary

886-2-23123456

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201505008RINA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.